SecBot SecBot
PRESS-RELEASE ·Filed Sep 22, 2026

INNV

InnovAge
BEARISH
Impact 6/10
Horizondays Processed1mo ago WireGlobeNewswire
Press release · Activist
Actionable Insight ▼ Bearish

Monitor the pricing and demand for the offering. A large secondary by insiders at a discount could pressure the stock. Watch for any subsequent insider filings or further selling by these funds.

DirectionBearish
Confidencehigh
Horizondays
Latest settled — T+20d
INNV ▲ +1.56% at T+20d
SHORT call ✗ call lost -1.56% · α vs SPY -0.87% · entry $9.00 → $9.14
Next anchor: T+60d in 7w
Latest observation: T+22 -10.47% FF3 residual α
Entry = T+0 close
Sep 22, 2026
via day close
T+1d
-1.78%
call +1.78% · α +1.70%
$8.84
settled 5w ago
T+5d
-2.22%
call +2.22% · α +1.55%
$8.80
settled 29d ago
T+20d
+1.56%
call -1.56% · α -0.87%
$9.14
settled 8d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

InnovAge announced a secondary offering of 10 million shares by selling stockholders Apax Partners and Welsh Carson, with a 1.5 million share greenshoe. InnovAge receives no proceeds, but the large secondary creates overhang and signals insider monetization.

Key Facts

  • Selling stockholders (Apax Partners and Welsh, Carson, Anderson & Stowe) are offering 10,000,000 shares of common stock.
  • Underwriters have a 30-day option to purchase up to an additional 1,500,000 shares.
  • InnovAge will not receive any proceeds from the offering.
  • InnovAge will bear the costs associated with the sale, excluding underwriting discounts and commissions.
  • Barclays, Goldman Sachs & Co. LLC and Wells Fargo Securities are joint book-running managers.

Financial Impact

10 million shares offered by selling stockholders; InnovAge receives no proceeds. At the last closing price (not stated), this represents a significant portion of float, creating dilution overhang.

dilutionshare price

Risk Factors

  • Secondary offering creates overhang and may depress share price.
  • Selling stockholders are major institutional investors, signaling potential lack of confidence.
  • InnovAge bears costs but receives no cash, offering no operational benefit.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3366874
13 reports for INNV
Performance horizon
80% Hit rate @ T+1 4 of 5 directional calls Went positive at some point 4 of 5 best @ T+5▲ +2.22%Sep 22, 2026
Filters
Rows
Reports for INNV — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
Insider Cluster
BEARISH ★ 6/10
$9.27awaiting T+1—$9.27 (−0.00%)
Oct 23, 2026
4d ago
Insider Cluster
BEARISH ★ 7/10
$9.27 $9.12▲ +1.62%▲ +2.18%$9.27 (−0.00%)
Oct 23, 2026
4d ago
Insider Cluster
BEARISH ★ 7/10
$9.27 $9.12▲ +1.62%▲ +2.18%$9.27 (−0.00%)
Oct 22, 2026
5d ago
DEFA14A
NEUTRAL ★ 2/10
$9.55 $9.27▼ −2.93%▼ −3.64%$9.27 (−2.93%)
Oct 22, 2026
5d ago
DEF 14A
NEUTRAL ★ 3/10
$9.55 $9.27▼ −2.93%▼ −3.64%$9.27 (−2.93%)
Sep 29, 2026
29d ago
Insider Cluster
BEARISH ★ 7/10
$8.80 $8.80· 0.00%▲ +0.18%$9.27 (−5.34%)
Sep 28, 2026
4w ago
Insider Cluster
BEARISH ★ 7/10
$8.98 $8.80▲ +2.00%▲ +1.80%$9.27 (−3.23%)
Sep 22, 2026
4w ago
Press Release
BEARISH ★ 5/10
$9.00 $8.84▲ +1.78%▲ +1.70%$9.27 (−3.00%)
Sep 22, 2026
5w ago
Press Release
BEARISH ★ 6/10
$9.00 $8.84▲ +1.78%▲ +1.70%$9.27 (−3.00%)
Aug 26, 2026
8w ago
Press Release
NEUTRAL ★ 1/10
$11.04awaiting T+1—$9.27 (−16.03%)
Showing 10 of 13

US Market Status

Market Closed — Opens Thu (12h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 22, 2026